先看重點
在1名受試者的24小時內,Apple Watch 3與動態心電圖平均相差-1.80次/分,Fitbit Charge 2相差-3.47次/分,兩者平均絕對誤差都接近6%。樣本只有1人(第一作者)和2款裝置,只能作初步參考,不能推廣。
證據類型
測量驗證研究/回顧
解讀依據
公開摘要
閱讀重點
參照與測量誤差
研究在問什麼
穿戴式裝置的心率準確性通常在實驗室的跑步機或功率車上測試,而不是在有家務和睡眠的普通一天裡。作者想檢驗兩款常見的腕戴裝置在連續24小時的真實使用中,與金標準心電圖的接近程度。
研究對象與方法
單受試者驗證研究:1名受試者(第一作者,29歲白種男性)同時佩戴Apple Watch 3、Fitbit Charge 2和作為參照的動態心電圖(Vrije Universiteit Ambulatory Monitoring System)24小時,共採集102,740次心跳。資料按5種情境劃分:靜坐、步行、跑步、日常活動(如做家務、刷牙)和睡眠。準確性用平均誤差、平均絕對誤差和平均絕對百分比誤差評價,並用Bland-Altman分析和一致性相關係數評估一致性。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1Apple Watch 3與心電圖相比,24小時內平均差值為-1.80次/分,平均絕對誤差為5.86%,平均一致性為95%。
- 2Fitbit Charge 2與心電圖相比,24小時內平均差值為-3.47次/分,平均絕對誤差為5.96%,平均一致性為91%。
- 3按作者的標準,兩款裝置在24小時整體及各情境下的誤差都在<±10%的可接受範圍內,只有Apple Watch 3在日常活動情境下例外。
- 4結果因情境而異,所以24小時平均表現良好,並不意味著每種活動都同樣準確。
限制與不確定性
- 1只有1名受試者佩戴,且他是第一作者,結果不一定適用於其他膚色、腕圍、佩戴鬆緊或心律的人。
- 2只測試了2款較早的型號(Apple Watch 3、Fitbit Charge 2),新款裝置和新版韌體不在其中。
- 3只記錄了一個24小時,僅反映當天的情境;作者自己也稱結果為初步結論。
- 4以上解讀僅基於摘要,摘要沒有給出各情境的具體數值。
日常健康啟示
結果提示,對這名受試者來說,這兩款裝置的腕部心率在普通一天裡與心電圖較為接近,支援把它們用於研究和日常監測。但這不代表你手上的裝置同樣準確,也不支援用穿戴式裝置心率來做診斷。
如何連結自己的資料
手錶測得的靜息心率和日常心率,更適合在同一裝置、同樣的佩戴方式(貼緊、同一隻手腕)下看趨勢。做家務等手臂活動不規律時誤差可能更大,單次讀數要謹慎對待。
如何理解這類證據
一致性取決於裝置、韌體、參照、族群和使用情境。相關性不等於一致性;驗證某個指標不等於已證明診斷或治療獲益。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Wrist-worn smart watches and fitness monitors (ie, wearables) have become widely adopted by consumers and are gaining increased attention from researchers for their potential contribution to naturalistic digital measurement of health in a scalable, mobile, and unobtrusive way. Various studies have examined the accuracy of these devices in controlled laboratory settings (eg, treadmill and stationary bike); however, no studies have investigated the heart rate accuracy of wearables during a continuous and ecologically valid 24-hour period of actual consumer device use conditions.
Objective
The aim of this study was to determine the heart rate accuracy of 2 popular wearable devices, the Apple Watch 3 and Fitbit Charge 2, as compared with the gold standard reference method, an ambulatory electrocardiogram (ECG), during consumer device use conditions in an individual. Data were collected across 5 daily conditions, including sitting, walking, running, activities of daily living (ADL; eg, chores, brushing teeth), and sleeping.
Methods
One participant, (first author; 29-year-old Caucasian male) completed a 24-hour ecologically valid protocol by wearing 2 popular wrist wearable devices (Apple Watch 3 and Fitbit Charge 2). In addition, an ambulatory ECG (Vrije Universiteit Ambulatory Monitoring System) was used as the gold standard reference method, which resulted in the collection of 102,740 individual heartbeats. A single-subject design was used to keep all variables constant except for wearable devices while providing a rapid response design to provide initial assessment of wearable accuracy for allowing the research cycle to keep pace with technological advancements. Accuracy of these devices compared with the gold standard ECG was assessed using mean error, mean absolute error, and mean absolute percent error. These data were supplemented with Bland-Altman analyses and concordance class correlation to assess agreement between devices.
Results
The Apple Watch 3 and Fitbit Charge 2 were generally highly accurate across the 24-hour condition. Specifically, the Apple Watch 3 had a mean difference of -1.80 beats per minute (bpm), a mean absolute error percent of 5.86%, and a mean agreement of 95% when compared with the ECG across 24 hours. The Fitbit Charge 2 had a mean difference of -3.47 bpm, a mean absolute error of 5.96%, and a mean agreement of 91% when compared with the ECG across 24 hours. These findings varied by condition.
Conclusions
The Apple Watch 3 and the Fitbit Charge 2 provided acceptable heart rate accuracy (<±10%) across the 24 hour and during each activity, except for the Apple Watch 3 during the daily activities condition. Overall, these findings provide preliminary support that these devices appear to be useful for implementing ambulatory measurement of cardiac activity in research studies, especially those where the specific advantages of these methods (eg, scalability, low participant burden) are particularly suited to the population or research question.
來源與署名
Accuracy of Consumer Wearable Heart Rate Measurement During an Ecologically Valid 24-Hour Period: Intraindividual Validation Study.
Nelson BW, Allen NB.
JMIR mHealth and uHealth · 2019-03-11
DOI: 10.2196/10828 ↗PubMed · 30855232 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
加速度計處理方法不同,身體活動與中風、心肌梗死的關聯曲線也不同
在英國生物銀行中,基線無心血管疾病的90237名成年人追蹤至2022年12月,共發生1298例中風和2031例心肌梗死;中高強度身體活動(MVPA)與這兩種結局的關聯曲線形狀,取決於加速度計資料的處理方法。就中風而言,只有機器學習法得到直線下降的風險;就心肌梗死而言,機器學習法和LFENMO法呈曲線下降,活動計數法呈直線下降。摘要沒有給出風險比,只能說明不同方法的結論不一致,不能說明哪種方法更正確,而且這些只是觀察性關聯。
Preventive Medicine
智慧手錶資料能當「證人」嗎:心率驗證得最充分,其餘證據參差
一項圍繞數字取證展開的系統評價和統合分析,梳理了四大主流品牌智慧手錶的驗證研究,發現心率是研究最多、也最準確的指標。步數、距離、能量消耗、活動分類和睡眠的驗證不夠一致,結果因品牌、方案和報告方式而異。摘要沒有給出彙總資料,且多數研究是在健康族群中、於實驗室內完成的,所以無法說明某一塊手錶對某個人在日常生活中的表現。
Forensic Science International
活動追蹤器:每天多走約1800步,對其他健康指標影響較小
這項傘形綜述彙總了39篇系統評價和統合分析,涉及163992名參與者;結果顯示使用活動追蹤器與身體活動增加相關(標準化均數差SMD為0.3–0.6),相當於每天多走約1800步、多步行40分鐘,體重減輕約1公斤。對血壓、膽固醇、糖化血紅蛋白、生活質量和疼痛的影響通常很小,且多數不顯著。摘要沒有說明這些專案裡追蹤器還搭配了什麼,也沒有說明各評價之間重疊多少,因此不能把效果完全歸功於裝置本身。
The Lancet Digital Health
七款睡眠追蹤裝置:識別睡著很準,識別醒著和睡眠分期較差
在睡眠實驗室裡,34名健康的年輕成年人連續三晚佩戴七款消費級睡眠追蹤裝置中的若干款。與多導睡眠監測相比,所有裝置識別睡眠都很準(靈敏度均不低於0.93),但識別清醒較差(特異度0.18–0.54),七款中有五款與研究用活動記錄儀(特異度0.39)持平或更好;睡眠分期的估計結果不穩定。受試者是18至35歲的健康成年人,臥床時間固定為8小時,每款裝置只在其中11至20人身上測試,因此對有睡眠問題的人幾乎沒有參考價值。
Sleep

